======= BLNK ======= == Gene Information == * **Official Symbol**: BLNK * **Official Name**: B cell linker * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29760|29760]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WV28|Q8WV28]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BLNK&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BLNK|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604515|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a cytoplasmic linker or adaptor protein that plays a critical role in B cell development. This protein bridges B cell receptor-associated kinase activation with downstream signaling pathways, thereby affecting various biological functions. The phosphorylation of five tyrosine residues is necessary for this protein to nucleate distinct signaling effectors following B cell receptor activation. Mutations in this gene cause hypoglobulinemia and absent B cells, a disease in which the pro- to pre-B-cell transition is developmentally blocked. Deficiency in this protein has also been shown in some cases of pre-B acute lymphoblastic leukemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, May 2012]. COMPLETENESS: complete on the 3' end. * **UniProt Summary**: Functions as a central linker protein, downstream of the B-cell receptor (BCR), bridging the SYK kinase to a multitude of signaling pathways and regulating biological outcomes of B-cell function and development. Plays a role in the activation of ERK/EPHB2, MAP kinase p38 and JNK. Modulates AP1 activation. Important for the activation of NF-kappa-B and NFAT. Plays an important role in BCR-mediated PLCG1 and PLCG2 activation and Ca(2+) mobilization and is required for trafficking of the BCR to late endosomes. However, does not seem to be required for pre-BCR- mediated activation of MAP kinase and phosphatidyl-inositol 3 (PI3) kinase signaling. May be required for the RAC1-JNK pathway. Plays a critical role in orchestrating the pro-B cell to pre-B cell transition. May play an important role in BCR-induced B-cell apoptosis. {ECO:0000269|PubMed:10583958, ECO:0000269|PubMed:15270728, ECO:0000269|PubMed:16912232, ECO:0000269|PubMed:9697839}. |SH2| |transmembrane receptor protein tyrosine kinase adaptor activity| |SH3/SH2 adaptor activity| |cytoplasmic ribonucleoprotein granule| |B cell differentiation| |B cell activation| |lymphocyte differentiation| |leukocyte differentiation| |humoral immune response| |lymphocyte activation| |inflammatory response| |transmembrane receptor protein tyrosine kinase signaling pathway| |hemopoiesis| |hematopoietic or lymphoid organ development| |immune system development| |enzyme linked receptor protein signaling pathway| |leukocyte activation| |cell activation| |defense response| |positive regulation of signal transduction| |intracellular signal transduction| |positive regulation of cell communication| |positive regulation of signaling| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-2.57| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|-2.07| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.06| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.95| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.92| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.87| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.84| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.84| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-1.83| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.8| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.79| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|-1.74| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|1.84| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|1.91| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.93| |[[:results:exp70|INK128 0.2μM R02 exp70]]|2.04| ^Gene^Correlation^ |[[:human genes:b:btk|BTK]]|0.6| |[[:human genes:r:rrm1|RRM1]]|0.479| |[[:human genes:n:nck1|NCK1]]|0.472| |[[:human genes:p:plcg2|PLCG2]]|0.45| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6272 * **Expression level (log2 read counts)**: 6.8 {{:chemogenomics:nalm6 dist.png?nolink |}}